Question 1

What is Sana Biotechnology's deferred tax assets and other non-current assets?

Accepted Answer

Sana Biotechnology (SANA) reported deferred tax assets and other non-current assets of $563K in Q1 2026.

Question 2

How has Sana Biotechnology's deferred tax assets and other non-current assets changed year-over-year?

Accepted Answer

Sana Biotechnology's deferred tax assets and other non-current assets decreased by 87.2% year-over-year, from $4.39M to $563K.

Question 3

What is the long-term trend for Sana Biotechnology's deferred tax assets and other non-current assets?

Accepted Answer

Over 5 years (2020 to 2025), Sana Biotechnology's deferred tax assets and other non-current assets has grown at a 75.6% compound annual growth rate (CAGR), from $190K to $3.17M.

Line item	March 31, 2026	December 31, 2025
Operating lease right-of-use assets	35,845	38,313
Intangible asset	59,195	59,195
Goodwill	140,627	140,627
Other non-current assets	563	3,173
TOTAL ASSETS	$373,593	$416,890
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$2,123	$1,669

Deferred Tax Assets and Other Non-Current Assets at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Returns & leverage

Where this comes from

FAQ

Ask your AI about Sana Biotechnology's deferred tax assets and other non-current assets.

Sana Biotechnology SANA Deferred Tax Assets and Other Non-Current Assets